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Abstract 
The diffusion dynamics of nanocarriers in the vitreous and the influence of nanocarrier 
physicochemical properties on these dynamics is an important aspect of the efficacy of 
intravitreal administered nanomedicines for the treatment of posterior segment eye diseases. 
Here we use fluorescence correlation spectroscopy (FCS) to determine liposome diffusion 
coefficients in the intact vitreous (DVit) of ex vivo porcine eyes using a modified Miyake-Apple 
technique to minimize the disruption of the vitreous fine structure. We chose to investigate 
whether the zeta potential of polyethylene glycol functionalized (i.e. PEGylated) liposomes 
altered liposome in situ diffusion dynamics in the vitreous. Non-PEGylated cationic 
nanocarriers have previously shown little to no diffusion in the vitreous, whilst neutral and 
anionic have shown diffusion. The liposomes investigated had diameters below 150 nm and 
zeta potentials ranging from -20 to +12 mV.  We observed that PEGylated cationic liposomes 
had significantly lower DVit values (1.14 μm2s-1) than PEGylated neutral and anionic liposomes 
(2.78 and 2.87 μm2s-1). However, PEGylated cationic liposomes had a similar biodistribution 
profile across the vitreous to the other systems. These results show that PEGylated cationic 
liposomes with limited cationic charge can diffuse across the vitreous and indicate that the 
vitreous as a barrier to nanocarriers (Ø < 500 nm) is more complicated than simply an 
electrostatic barrier as previously suggested.  
 
1. Introduction 
Nanomedicines have been proposed as one of a number of next generation clinical therapies 
for the treatment of posterior segment eye diseases  (Bochot and Fattal, 2012; Liu et al., 2012; 
del Pozo-Rodríguez et al., 2013). Posterior segment eye diseases - such as diabetic 
retinopathy and age-related macular degeneration - are vision threatening, remain 
challenging to treat and increasingly affect a larger proportion of the populations of industrial 
nations due to increased life expectancy, poor lifestyle and diet  (Congdon et al., 2003; Yau et 
al., 2015). To access the posterior segment of the eye and bypass ocular physiological barriers, 
nanomedicines are often injected into the vitreous  (Geng et al., 2014; Li et al., 2016; Peeters 
et al., 2005; Zhao et al., 2017;  Giannaccini et al., 2014; Natarajan et al., 2014; Sakurai et al., 
2001; Thakur et al., 2014). The vitreous fills the vitreous cavity of the eye and has a number of 
physiological roles (e.g. the regulation of oxygen tension, buffering metabolite diffusion etc. 
(Foulds, 1987; Holekamp, 2010; Holekamp et al., 2005; Sebag, 2009; Stefansson and Loftsson, 
2006)). The vitreous is a hydrogel comprised predominantly of water in a collagen-
glycosaminoglygan network (CGN). The CGN comprises of collagen fibres (mainly type II 
fibrils packed in parallel) separated by random coil glycosaminoglycans (predominantly 
hyaluronic acid). The density of the CGN varies across the eye with fibrils and fibres 
predominantly orientating antero-posterior (from lens to retina)  (Foulds, 1987; Le Goff and 
Bishop, 2008; Kodama et al., 2013; Mains and Wilson, 2013; Scott, 1992).  
 The vitreous has previously been shown to be a barrier to nanocarriers, with the size and 
surface charge of nanocarriers being argued as crucial factors as to whether nanocarriers can 
diffuse or are immobilized. The CGN is porous (pores are sometimes described as liquid 
channels) with porosity changing with CGN density throughout the eye. In the central 
vitreous, a region of low CGN density, pore size has been shown to vary from 500 nm to over 1 
μm  (Xu et al., 2013). However, nanocarriers with dimensions greater than 500 nm have been 
shown to exhibit slow or limited diffusion from injection sites  (Xu et al., 2013). This has been 
attributed to either a limited mobility or immobility through CGN pores. Additionally the CGN 
is viewed as having a net negative charge due to the large negative charge of 
glycosaminoglycans  (Mains and Wilson, 2013). Nanocarriers with high cationic zeta 
potentials (≥ +20 mV) but with diameters below 500 nm have shown limited to no diffusion 
from the injection site  (Xu et al., 2013). This has been attributed to strong attractive 
electrostatic interactions with the CGN. Conversely both anionic and neutral nanocarriers 
have been reported to readily diffuse throughout the vitreous. This has lead to the notion of 
the vitreous as an electrostatic barrier to nanocarriers (Mains and Wilson, 2013).   
 
The functionalization of nanocarrier surfaces with polyethylene glycol (i.e. PEGylation) has 
been shown to improve circulation/residency time of nanocarriers and is widely used in 
nanomedicines. Previous studies have shown that PEGylated neutral polymeric nanoparticles 
diffuse in the central vitreous with similar values to anionic polymeric nanoparticles 
(DBuffer/DVit =1.5-3.2 and 2.2-3.5 respectively) (Martens et al., 2013; Xu et al., 2013). The 
diffusion dynamics of both PEGylated cationic and PEGylated anionic nanocarriers in the 
vitreous has not been reported. To determine diffusion coefficients we used fluorescence 
correlation spectroscopy (FCS). FCS measures changes in the intensity of emitted light from 
fluorophores and fluorophore labeled/containing species (e.g. nanocarriers, proteins etc.) 
across a fixed focal volume, resulting in data as a pulse sequence  (Elson and Magde, 1974; 
Hess et al., 2002; Kristensen et al., 2016; Magde et al., 1974). Autocorrelation analysis of the 
pulse lag-time provides information about the diffusive speed of the fluorescent species. All 
previous studies on nanocarrier diffusion in the vitreous that we are aware of have utilized 
particle tracking (Xu et al., 2013; Martens et al., 2013; Käsdorf et al., 2015), which has distinct 
advantages (particularly around particle flight dynamics) but is not a bulk system 
measurement (i.e. reflective of thousands of carriers). FCS of fluorescent nanocarriers allows 
the diffusion coefficient of a system to be determined from thousands of nanocarriers in 
crowded media. Furthermore, through cross-correlation of autocorrelation differences 
between different fluorophores in the nanocarrier we can eliminate any uncertainty 
associated with fluorophore leakage (if the fluorophore is not covalently bound to the carrier) 
and potential chemical reactions between a fluorophore and environmental components. 
Additionally most previous reports on nanocarrier diffusion in the vitreous have used the 
bovine vitreous as a model. Literature however suggest that the porcine vitreous, in terms of 
structure and visco-elastic properties, is a better model for the human vitreous (Swindle et al., 
2008) and is why the porcine eye is chosen as a model in this study.  
 
Here we use a modified Miyake-Apple technique to introduce a window into the vitreous of an 
ex vivo porcine eye (see Figure 1) and for the first time determine the diffusion coefficients of 
PEGylated liposomes in the intact vitreous using FCS. We compare these values to diffusion 
coefficients of PEGylated liposomes in HEPES saline buffer. We show the biodistribution of 
PEGylated liposomes in the ex vivo porcine eye 1 hour after intravitreal injection and discuss 
this data in light of the determined diffusion coefficients in the vitreous.   
 
2. Materials and methods 
2.1 Materials 
Cholesterol (Chol), 1,2-distearoyl-3-trimethylammonium-propane (DSTAP), 1,2-distearoyl-
sn-glycero-3-phosphocholine (DSPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
methoxy(polyethylene glycol)-2000 (DSPE-2000) and 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-lissamine rhodamine B (DPPE-Rhod) were all purchased for Avanti 
Polar Lipids (Alabama, USA), all lipids was >98-99% pure.  Calcein (purity >93%), HEPES 
(purity >99.5%) and NaCl (99%) were all purchased from SigmaAldrich (Brønby, Denmark). 
FluoSpheres (25 nm and 47 nm) and M-1 embedding matrix and were purchased from 
ThermoFisher (Paisley, UK). Porcine eyes (Danish Landrace pigs) were obtained from local 
abattoirs within 2 hours of slaughter.  
 
2.2 Methods 
2.2.1 Liposome preparation: The 3 liposome systems were prepared by hydrating dry lipid 
films with a 10 mM calcein (SigmaAldrich) in 10 mM HEPES saline buffer (pH 7.4, 150 mM 
NaCl) followed by extrusion through a 100 nm filter at 75 °C  (Andresen et al., 2004). Non-
encapsulated calcein was removed by size exclusion chromatography on a Sephadex G-50 
column using a 10 mM HEPES saline eluent. The anionic system comprised of DSPC, Chol, 
DSPE-PEG2000 and DPPE-Rhod (54.8:40:5:0.2 mol%) whilst the neutral and cationic systems 
comprised of DSPC, DSTAP, Chol, DSPE-PEG2000 and DPPE-RhoB (44.8:10:40:5:0.2 and 
24.8:30:40:5:0.2 mol% respectively).  
 
2.2.2 Liposome characterisation: The hydrodynamic diameter and surface charge of the 
liposomes were measured on a Brookhaven ZetaPALS, Zeta potential analyzer. Diameters 
were measured by dynamic light scattering (DLS) in 10 mM HEPES saline buffer whilst zeta 
potentials were measured in 10 mM HEPES in 5% glucose solution. Phospholipid 
concentrations were determined by quantifying the phosphorous content in the purified 
liposomes samples using ICP-MS. 
 2.2.3 FCS: Porcine eyes were obtained from a local abattoir, kept on ice and used within 2 
hours of slaughter. Excess connective tissue was removed from the eyes. A Miyake-Apple 
window was introduced into the vitreous by removing part of the sclera and mounting a 
chamber slide using super glue  (Davis et al., 2004; Pereira et al., 2009). This setup enabled 
optical access to the vitreous while preserving vitreous fine structure. Eyes were injected with 
100 μL of a 1 mM liposome suspension in 10 mM HEPES saline buffer (pH 7.4 approximately 5 
mm posterior to the corneal limbus at a depth of approximately 0.8 using a 27G needle  
(Mains et al., 2011) ). The porcine eye was not perfused to eliminate convection and active 
transport factors.  A low concentration of liposomes was used to eliminate hydrostatic and 
osmotic effects between liposomes  (Brady, 1993). Control experiments with liposomes in 
HEPES saline was preformed in 8 chamber slides in a total volume of 500 μL, per well. 
 
FCS was performed on a custom-built fluorescence microscope using 2 photon excitation as 
previously described in  (Brewer et al., 2010; Kubiak et al., 2011).  FCS data was analysed 
using the software SimFCS  (Beechem and Gratton, 1988).  A laser wavelength of 894 nm, a 
sampling frequency of 20 kHz and a 60x 1.2 NA water emersion objective were used. 
Measurements were taken in the central vitreous (Sebag, 1992), at least 100 μm from the 
cover glass thereby eliminating edge effects. The size of the focal volume was determined by 
calibrating the system with FluoSpheres (Thermofisher, Ø 25 nm and 47 nm) in buffer and 
fitting with the locked diffusion coefficients (17.2 μm2s-1 and 9.1 μm2s-1 respectively) 
determined by the Stokes-Einstein equation assuming temperature to be 293 K and the 
dynamic viscosity of water to be 1 cP. The focal waist, at 1/e, was found to be 459 nm for the 
894 nm laser (global χ2 <0.01) and, using 2-photon formulas  (Krichevsky and Bonnet, 2002).  
This corresponds to a two photon beam waist of 324 nm and the focal volume was calculated 
to be 0.8 μm3. Control experiments of liposome diffusion were made in 10mM HEPES saline 
buffer (pH 7.4). Data files were analyzed in sets of 16k points, using the large vector 
correlation (SimFCS). Data sets that deviated from the autocorrelation function in shape, e.g. 
showed bumps that could be attributed to noise related events, were deleted. The resulting 
correlation average files (approx. 10 per set) were then fitted as described in  (Brewer et al., 
2010)  to find the bulk diffusion constant of the liposomes (see Figure 2). 
 
2.2.4 Liposome biodistribution: Porcine eyes were obtained and injected as described in the 
FCS methodology. After injection, porcine eyes were kept static and moist at room 
temperature for 1 hour before snap freezing at −179°C in an isopentane/liquid nitrogen bath 
to minimize water crystal size. The eyes were embedded in M-1 embedding matrix before 
cryo-sectioning into 40 μm thick sections at 500 μm intervals moving from the lens to the 
retina. To simplify the biodistribution, the vitreous was divided into 4 segments (1-4), moving 
from the back of the lens (1) to the vitreoretinal interface (4), with each segment comprising 
of 4 tissue sections (each section was approx. 1.5 cm2). Images of sections were captured with 
confocal microscopy over the whole cross-section of the vitreous cavity. The red fluorescence 
signal (associated with DPPE-Rhod) in each image was quantified using ImageJ software. To 
eliminate possible noise contributions, only pixels with an intensity ≥ 50 arbitrary units were 
counted. Counts were then averaged for all images within each section, before normalizing to 
the total pixel count of each eye. Red fluorescence was chosen to improve signal to noise 
intensity whilst removing contributions from collagen auto-fluorescence.  
 
3. Results and discussion 
3.1 Liposome characterization and diffusion   
Liposomes with similar sizes and size polydispersity but different surface charges were 
prepared (see Table 1). We chose a zeta potential for the anionic system to be within 
physiological range (eukaryotic cell membrane zeta potentials range usually within -15 to -30 
mV  (Alqawlaq et al., 2014; Giannaccini et al., 2014; Koo et al., 2012; Liu et al., 2011; Peeters et 
al., 2005)) and for the cationic system a relatively low zeta potential. Cationic nanocarriers 
with significantly high positive zeta potentials as well as liposomes with large concentrations 
of DSTAP have both been shown to be significantly cytotoxic  (Aramaki et al., 1999; Filion and 
Phillips, 1997; Nel et al., 2009). The PEG composition was kept at 5 mol% to ensure a brush 
PEG configuration  (Garbuzenko et al., 2005).     
 
FCS autocorrelation curves for all systems, whether in buffer or vitreous, could be fitted 
assuming normal rather than abnormal diffusion. Figure 3 shows the diffusion coefficients of 
the liposome systems in buffer and in porcine vitreous. Good cross-correlation between the 
red and green detector channels in the FCS (associated with calcein and DPPE-RhoB 
respectively in the liposome aqueous core and membrane) was observed. This indicated that 
neither fluorophore leaked from the liposomes and that liposomes diffused intact through 
both buffer and vitreous. The average of the apparent diffusion coefficients of the liposome 
systems, as determined from the red and green detector channels, in HEPES saline buffer 
(DBuff) were 5.36, 4.82 and 5.11 μm2s-1 for the anionic, neutral and cationic systems 
respectively.  In HEPES saline buffer all liposomes showed similar diffusion coefficients and 
no significant difference (one-way ANOVA p>0.66). The FCS determined diameters of the 
liposomes (data not shown) were similar but slightly smaller than those determined by DLS. 
Nanocarrier diameters determined by FCS and DLS do not always correlate due to a range of 
factors, including laser induced localized temperature effects, assumptions over medium 
dynamic viscosity etc.  (Drabik et al., 2016; Khan et al., 2016). However, both techniques 
indicated that no significant liposome agglomeration occurred, even at physiological salt 
concentrations (i.e. 150 mM) (Stylianopoulos et al., 2010) where repulsive potential energy 
components (e.g. electrostatic repulsion) become negligible compared to low/no salt 
solutions. In the vitreous all liposome systems showed reduced diffusion coefficients (see 
Figure 3B). The average apparent diffusion coefficients (DVit) were 2.87, 2.78 and 1.14 μm2s-1 
for the anionic, neutral and cationic systems respectively. Comparing the effective diffusion in 
the vitreous between the different liposome systems it can be seen that the cationic liposomes 
diffuse slower than the anionic and neutral liposomes (p<0.01). This indicates that the 
observed reduction of the diffusion coefficients cannot solely be explained by the increased 
dynamic viscosity of the vitreous compared to saline buffer. 
 
For the neutral system, the ratio of buffer diffusion coefficient to vitreous diffusion coefficient 
(i.e. DBuff/DVit., see Figure 4) was 1.73 and in general agreement with previously reported 
ratios (between 1.8-3.2) for PEGylated polymeric nanoparticles in the bovine vitreous. These 
polymeric nanoparticles had diameters from 100 to 200 nm and zeta potentials between -4 to 
-8 mV  (Käsdorf et al., 2015; Martens et al., 2013; Peeters et al., 2005; Xu et al., 2013).  
Surprisingly, the DBuff/DVit. ratio of the anionic liposome system (i.e. 1.87) is lower than 
reported values (between 2.2-3.2) for carboxylic acid functionalized anionic polymeric 
nanoparticles (Martens et al., 2013; Xu et al., 2013).  These -COOH functionalized polymeric 
nanoparticles had zeta potentials ranging from -49 to -65 mV and diameters between 100 to 
200 nm. The observed lower DBuff/DVit. ratio for the anionic liposome system likely reflects a 
range of factors. These include physiological factors associated with intraspecies and 
interspecies (bovine eye studies dominate the literature) variations in CGN density, as well as 
differences in the physicochemical properties of nanocarrier systems. In fact literature 
suggests that the porcine vitreous has a lower loss modulus, hence a lower dynamic viscosity 
than the bovine vitreous  (Filas et al., 2014; Nickerson et al., 2008). However the large 
variability on the viscosity measurements within each species prohibits quantification of the 
expected difference in DVit between porcine and bovine. Additionally liposomes are highly 
deformable compared to rigid solid polymeric nanoparticles and this flexibility may facilitate 
diffusion through CGN pores, particularly pores with sizes that approach that of the 
nanocarrier.  These factors together are a possible explanation for the slightly lower DBuff/DVit 
observed for neutral and negative liposomes compare to what has previously been reported  
(Käsdorf et al., 2015; Martens et al., 2013; Xu et al., 2013).  
 
The cationic liposome system showed the greatest decrease in diffusion coefficient moving 
from buffer to vitreous and the largest DBuff/DVit. ratio (i.e. 4.48). Xu et al. reported a DWater/DVit 
ratio of 2200 for amine functionalized polystyrene nanoparticles (Ø = 181 nm, +39 mV zeta 
potential) (Xu. et al., 2013) whilst for a similar amine functionalized polystyrene system (Ø = 
107 nm, +39 mV zeta potential) Martens et al. reported a DBuff/DVit. ratio of 13  (Martens et al., 
2013). Both groups reported that the cationic polymeric nanoparticles did not significantly 
diffuse away from the injection site. If we had observed similar values for the cationic 
liposome system we would have obtained DVit values between 2.2x10-3 and 0.37 μm2s-1. There 
are a number of challenges with directly comparing data between the systems. Similar to the 
anionic systems, there are both differences in physiology and material properties. These 
previous studies used bovine vitreous, which has a higher viscosity than the porcine vitreous 
(Filas et al., 2014; Nickerson et al., 2008). The difference in viscosity could explain the lower 
DVit reported by Martens et al. but not the DVit reported by Xu et. al. The difference in zeta 
potential between the cationic liposomes and the cationic polymeric nanoparticles is an 
additional significant difference (i.e. +11.9 mV versus +39 mV). The CGN is viewed as having a 
net negative charge and it would be easy to argue that large cationic charge increases 
electrostatic attraction between nanocarrier and the CGN, resulting in little or no diffusion.  As 
the surface charge drops, the likelihood of strong electrostatic attraction diminishes and 
nanocarrier diffusion increases through the CGN. If we assume that the porcine vitreous has a 
similar sodium salt concentration to human vitreous (i.e. approximately 150 mM) (Kokavec et 
al., 2016),  then the Debye screening length for the vitreous would be approximately 0.7 nm  
(Freudenberg et al., 2007). This reduced screening length would promote attractive 
interactions between nanocarriers with high surface energies whilst substantially reducing 
electrostatic repulsion, leading to nanocarrier agglomeration (i.e. a reduction of the system 
potential energy). Our systems showed no agglomeration in buffer with salt concentrations 
similar to the vitreous. Other reported studies measure particle size in either pure water or 
low salt concentrations (e.g. 10 mM) which greatly increases the Debye screening length and 
therefore maximizes electrostatic repulsion between nanocarriers. This opens the question as 
to whether previous observations regarding limited mobility or immobilized cationic non-
PEGylated nanocarriers are a result of nanocarrier agglomeration rather than nanocarrier-
CGN interactions. Agglomerated nanocarriers (even if agglomerates contain only a small 
number of nanocarriers) would increases particulate size resulting in inhibited diffusion 
through CGN pores rather than reducing diffusion through electrostatic attraction.  
 
All the liposomes systems contain 5 mol% DSPE-PEG2000, which ensures that surface PEG is 
in a brush configuration  (Garbuzenko et al., 2005) and therefore long circulating. It has been 
calculated that the brush configuration of PEG extends approximately 4.5 nm from the 
liposome surface (mushroom configuration extends 3.3 nm) (Garbuzenko et al., 2005). It 
would not be unreasonable to assume that PEG chains (either in brush or mushroom 
configuration) would sterically inhibit the distance of approach between liposome and CGN, 
thereby reducing electrostatic interactions. As the liposomes are in the liquid ordered phase 
and have a high cholesterol content (40 mol%), it also seems unlikely that DSPE-PEG2000 
phospholipids could be easily displaced to allow the liposome to approach the CGN to within ≤ 
1 nm.  Furthermore, studies on PEGylated polymeric nanoparticles have shown that 
PEGylation eliminates any bound fraction of nanoparticles in the vitreous, indicating that PEG 
chains inhibit nanoparticle-CGN interactions (Käsdorf et al., 2015). Our results show that, 
even with brush configuration PEG surface densities that should inhibit nanoparticle-CGN 
interactions and shield electrostatic interactions, weak electrostatic interactions occurred 
between the cationic system and the CGN. The argument for weak interactions over strong 
interactions is supported by the observed diffusion of cationic liposomes in the vitreous. As 
there appears to be weak electrostatic attraction between the cationic system and the CGN, it 
could be that there is a weak electrostatic repulsion between the anionic system and the CGN. 
This repulsion in combination with PEGylation could account for the lower DBuff/DVit. ratio 
observed for the anionic liposomes compared to anionic polymer systems.    
 
There are a number of possible physiological explanations for the observation regarding 
cationic liposomes. It may be that the porcine eyes used for the cationic liposomes had lower 
CGN densities compared with bovine eyes, minimizing nanocarrier-CGN interactions and 
decreasing vitreous viscosity. This could also possibly explain why the anionic liposomes had 
a lower DBuff/DVit ratio than anionic polymeric nanoparticles in the bovine vitreous.  It may be 
that porcine vitreous has a higher salt concentration than bovine vitreous. The bovine 
vitreous would therefore have a longer Debye screening length causing increased electrostatic 
interactions between nanocarrier and the CGN. It may be that salt concentrations within the 
vitreous are not uniform and that at the submicron scale there may be regions of lower salt 
concentration which would greatly increase the Debye screening length and therefore 
overcome the steric factor associated with PEG chains. Combined with these low salt regions 
could be high CGN density regions with small pores, which would also increase the probability 
of electrostatic interactions. These final two explanations are undermined by the lack of any 
observed anomalous diffusion in the autocorrelation curves as it could be envisaged that 
anomalous diffusion (e.g. Lévy flight and trap dynamics) would occur if the vitreous had 
submicron regions with substantial variations in physicochemical properties.  
 
3.2 Liposome distribution in the eye 
The biodistribution of the liposomes was tested to determine whether liposome surface 
chemistry and corresponding diffusion coefficient influenced distribution dynamics in the 
porcine eye (see Figure 5). To aid analysis and presentation, the vitreous was divided into 4 
segments (1-4), moving from the lens (1) to the vitreoretinal interface (4). Figure 6 shows the 
biodistribution data and the median and interquartile range for the liposome systems. Mean 
values were avoided to eliminate large values outweighing small values in normalized 
fluorescence.  Taking the median values across the 4 segments for both the anionic (Figure 
6A) and neutral systems (Figure 6B), it can be seen that there is a relatively even distribution 
for both sets of liposomes (0.15-0.32 for the anionic and 0.16-0.27 for the neutral). One hour 
post injection the cationic system (Figure 6C) showed an uneven distribution with the largest 
median values (0.32 and 0.4) located in the middle segments of the vitreous. The cationic 
system also showed the lowest median value for the front of the vitreous (0.05), one hour 
after injection, compared with the other two systems. As the intravitreal injection occurred 
approximately 5mm from the corneal limbus (at the segment 1 and 2 interface) the elevated 
levels in the middle of the vitreous might reflect a combination of slower diffusion and 
convection currents associated with injection. To determine if this might be the case, we 
repeated the biodistribution study of the cationic system but snap-froze the eyes after 2 hours 
to account for the slower diffusion rate (see Figure 6D). It could be seen that after 2 hours 
both the median values for segments 1 and 4 (front and back vitreous) had increased to 0.16 
and 0.25, whilst the median values of the middle vitreous had decreased.  
 
Overall, there is little substantial difference in distribution between the liposome systems. We 
observed no significant compartmentalization of liposomes into specific segments (e.g. 
remaining at the injection site, preferential diffusion to the vitreoretinal region etc.) under 
passive diffusion conditions. This indicates that PEGylation eliminated any bound fractions of 
liposomes as previously shown with polymeric nanocarriers  (Käsdorf et al., 2015; Xu et al., 
2016). Furthermore, the weak electrostatic interactions observed had no apparent effect on 
the distribution of the liposomes. Although the low diffusion rate of the cationic system did 
influence short-term biodistribution, this distribution did not remain with extended time.  
 
4. Conclusions 
Our work demonstrates that PEGylated cationic liposomes can diffuse through the vitreous 
and can reach the vitreoretinal region. PEGylation did not completely inhibit electrostatic 
interactions and weak electrostatic attraction is the likely explanation for the reduced 
diffusion rate of PEGylated cationic liposomes compared to the anionic and neutral systems.  
High cationic charge in nanocarriers is associated with significant cytotoxicity due to cell 
membrane disruption. However, it is generally accepted that nanocarriers with cationic 
surface charge have increased interactions with cell membranes due to electrostatic 
attraction and a greater likelihood of being endocytosed. Our results show that the 
combination of PEGylation with cationic surface charge will not inhibit nanocarriers form 
reaching the vitreoretinal region. This presents a strong argument for combing the benefits of 
PEGylation and cationic charge in nanocarriers as systems for the treatment of posterior 
segment diseases. However, many fundamental questions still remain regarding the nature of 
nanocarrier-CGN dynamics and whether these can be exploited to maximize nanocarrier 
therapeutic performance.  
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Figure legends 
 
Figure 1. Schematic diagrams: A) The liposomes comprised of phospholipids, cholesterol, a 
calcein loaded aqueous core (green), rhodamine (red hexagons) conjugated phospholipids 
and PEG (black lines) conjugated phospholipids; B) Illustration showing the experimental 
setup for the ex vivo porcine eye used for FCS analysis.  A modified Miyake-Apple technique 
was used to introduce a window into the vitreous (Liposomes shown as red border/green 
core spheres, whilst the laser light is shown in blue).  
 
 
Figure 2: Example normalized autocorrelation curves of liposomes in the vitreous of the ex 
vivo porcine eye. All autocorrelation curves, whether in the vitreous or buffer, could be fitted 
assuming normal diffusion.   
 
Figure 3. A) The FCS determined diffusion coefficients of liposomes in 10 mM HEPES saline 
buffer (n = 3 per liposome system); B) The FCS determined diffusion coefficients of liposomes 
in ex vivo porcine vitreous (n = 5 per liposome system). In both figures the diffusion 
coefficients as determined by the red channel (red column), green channel (green column), 
cross correlation (gray column) and the average of the combined red and green channels 
(black columns) are shown. Black error bars show the SEM for each coefficient.  
 
 
Figure 4. The diffusion coefficient ratios between buffer and vitreous  (DBuff/DVit) for the 
liposome systems determined from the red channel (red column), green channel (green 
column), cross correlation (gray column) and the average of the combined red and green 
channels (black columns) FCS data. Black error bars show the error (as determined by 
propagation of the SEM) for each ratio. The average DBuff/DVit values for the anionic, neutral 
and cationic systems are 1.87, 1.73 and 4.48 respectively.  
 
Figure 5. An example of a vitreous cross section imaged by confocal microscopy showing red 
fluorescence (A) and corresponding bright field (B) images. Scale bar corresponds to 40 μm. 
This image was made with the anionic liposomes. The red fluorescence is associated with  
DPPE-Rhod.  
 
 
Figure 6. The median and interquartile range of liposome biodistribution after intravitral 
injection into the ex vivo porcine eye. The X axis refers to section in the eye from 1= front 
vitreous-posterior lens to 4 posterior vitreous-vitreoretinal interface; A) Anionic liposomes 
1h post injection B) Neutral liposomes 1h post injection. C) Cationic liposomes 1h post 
injection. D) cationic liposomes 2h post injection. 
 
Table and Table legend  
 
Liposome Diameter [nm] PDI Zeta-potential [mV] 
Anionic 121 ±5 0.05 ±0.01 -20.5 ±4 
Neutral 135 ±2 0.04 ±0.01 0.0 ±2 
Cationic 137 ±5 0.04 ±0.01 11.9 ±2 
 
Table 1. Liposome size and zeta potential. Liposome diameters measured by DLS in 10 mM 
HEPES saline buffer. Mean ± SEM (n = 5 per liposome system) with the standard error of the 
mean (SEM). Liposome zeta potential measured in 10mM HEPES 5% Glucose solution. Mean ± 
SEM (n = 5 per liposome system).  
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